Cita APA

Hasselbalch, H., Skov, V., Kjær, L., Ellervik, C., Poulsen, A., Poulsen, T., & Nielsen, C. (2021). COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon. Cytokine Growth Factor Rev.

Chicago Style Citation

Hasselbalch, H.C., V. Skov, L. Kjær, C. Ellervik, A. Poulsen, T.D Poulsen, i C.H Nielsen. "COVID-19 As a Mediator of Interferon Deficiency and Hyperinflammation: Rationale for the Use of JAK1/2 Inhibitors in Combination With Interferon." Cytokine Growth Factor Rev 2021.

Cita MLA

Hasselbalch, H.C., et al. "COVID-19 As a Mediator of Interferon Deficiency and Hyperinflammation: Rationale for the Use of JAK1/2 Inhibitors in Combination With Interferon." Cytokine Growth Factor Rev 2021.